Agios Pharma (8AP) Q4 2024 Earnings Report
DE:8AP Q4 2024 EPS Results
- Actual EPS
- -EUR 1.29
- Consensus EPS
- -EUR 1.51
- Beat/Miss
- Beat by +EUR 0.22
- One Year Ago EPS
- -EUR 1.53
DE:8AP Q4 2024 Revenue Results
- Actual Revenue
- EUR 9.59M
- Expected Revenue
- EUR 8.38M
- Beat/Miss
- Beat by +EUR 1.21M
- YoY Revenue Growth
- +51.06%
Earnings Announcement Details
- Quarter
- Q4 2024
- Date
- 02/13/2025
- Time
- Before Open
- Conference Call
- Thursday, February 13, 2025
DE:8AP Upcoming Earnings
Agios Pharma's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q4 2024 Earnings Call Audio
DE:8AP Q4 2024 Earnings Call
0:00 / 0:00
Q4 2024 Earnings Slide Deck
Q4 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:8AP Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | -1.11- | -1.59 | ― | ― |
| Jul 30, 2026 | 2026 (Q2) | -1.48-1.51 | -1.73 | 12.44% (+0.21) | |
| Apr 29, 2026 | 2026 (Q1) | -1.61-1.51 | -1.39 | -9.03% (-0.13) | |
| Feb 12, 2026 | 2025 (Q4) | -1.75-1.66 | -1.29 | -29.17% (-0.38) | |
| Oct 30, 2025 | 2025 (Q3) | -1.70-1.59 | 14.5 | -110.97% (-16.09) | |
| Jul 31, 2025 | 2025 (Q2) | -1.62-1.73 | -1.51 | -14.20% (-0.21) | |
| May 01, 2025 | 2025 (Q1) | -1.58-1.39 | -1.3 | -6.90% (-0.09) | |
| Feb 13, 2025 | 2024 (Q4) | -1.51-1.29 | -1.53 | 15.79% (+0.24) | |
| Oct 31, 2024 | 2024 (Q3) | 13.6014.50 | -1.47 | 1089.02% (+15.97) | |
| Aug 01, 2024 | 2024 (Q2) | -1.43-1.51 | -1.35 | -11.92% (-0.16) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
